Quinapril (quinapril hydrochloride) NDC 65862-619

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-619Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0619Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65862-619-19	65862061919	10000 TABLET, FILM COATED in 1 BOTTLE (65862-619-19)Marketed from Apr 29, 2013
65862-619-30	65862061930	30 TABLET, FILM COATED in 1 BOTTLE (65862-619-30)Marketed from Apr 29, 2013
65862-619-78	65862061978	10 BLISTER PACK in 1 CARTON (65862-619-78) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65862-619-10)Marketed from Apr 29, 2013
65862-619-90	65862061990	90 TABLET, FILM COATED in 1 BOTTLE (65862-619-90)Marketed from Apr 29, 2013
65862-619-99	65862061999	1000 TABLET, FILM COATED in 1 BOTTLE (65862-619-99)Marketed from Apr 29, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Quinapril
Generic name (nonproprietary): quinapril hydrochloride
Active ingredients: Quinapril hydrochloride — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202725
Marketing start: Apr 29, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)
Identifiers: Product ID 65862-619_5263abd5-ce46-4918-9bb0-9632861bcbc9SPL ID 5263abd5-ce46-4918-9bb0-9632861bcbc9SPL set ID 93e6e668-5306-4f26-81d8-cbc3a7a5e787RxCUI 312748, 312749, 312750, 314203UNII 33067B3N2MUPC 0365862618900, 0365862617903, 0365862619907
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862061919 followed by a unit qualifier and the quantity

Package 65862-0619-19. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 15, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hypertension Quinapril tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with quinapril tablets, USP. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithr…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202725

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202725
Product	Strength	Form · route	Labeler	Product NDC
Quinaprilquinapril hydrochloride	Quinapril hydrochloride 10 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	63629-7934
Quinaprilquinapril hydrochloride	Quinapril hydrochloride 40 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-620
Quinaprilquinapril hydrochloride	Quinapril hydrochloride 5 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-617
Quinaprilquinapril hydrochloride	Quinapril hydrochloride 10 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-618
Quinaprilquinapril hydrochloride	Quinapril hydrochloride 10 mg/1	Tablet, Film coatedOral	Proficient Rx LP	63187-874